摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

α-ethoxy-o-xylene | 64988-08-5

中文名称
——
中文别名
——
英文名称
α-ethoxy-o-xylene
英文别名
ethyl-(2-methyl-benzyl)-ether;11-Aethoxy-1.2-dimethyl-benzol;Aethyl-(2-methyl-benzyl)-aether;Aethyl-o-tolubenzyl-aether;Ethyl-<2-methyl-benzyl>-ether;2-Methyl-benzyl-ethylether;(2-Methylphenyl) methanol, ethyl ether;1-(ethoxymethyl)-2-methylbenzene
α-ethoxy-o-xylene化学式
CAS
64988-08-5
化学式
C10H14O
mdl
——
分子量
150.221
InChiKey
LQKYYHVKCCFMLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    203 °C(Press: 768 Torr)
  • 密度:
    0.9464 g/cm3(Temp: 17.5 °C)
  • 保留指数:
    1171

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    sodium ethanolate邻甲基氯化苄乙醇 为溶剂, 反应 14.0h, 以90%的产率得到α-ethoxy-o-xylene
    参考文献:
    名称:
    Regioselective ring opening in substituted benzocyclopropenes. An alternative or complementary mechanism for electrophilic substitution involving attack at .alpha. bond
    摘要:
    DOI:
    10.1021/ja00543a032
点击查看最新优质反应信息

文献信息

  • A Versatile Iridium(III) Metallacycle Catalyst for the Effective Hydrosilylation of Carbonyl and Carboxylic Acid Derivatives
    作者:Yann Corre、Vincent Rysak、Xavier Trivelli、Francine Agbossou-Niedercorn、Christophe Michon
    DOI:10.1002/ejoc.201700801
    日期:2017.9.1
    IrIII metallacycle rapidly and selectively catalyses the reduction of various esters, carboxylic acids, ketones, and aldehydes. The reactions proceed in high yields at room temperature by hydrosilylation followed by desilylation. Depending on the substrate, esters are reduced to alcohols or ethers and carboxylic acids to alcohols or aldehydes.
    通用的Ir III金属环可快速,选择性地催化各种酯,羧酸,酮和醛的还原。该反应在室温下通过氢化硅烷化然后脱甲硅烷基化以高收率进行。取决于底物,酯被还原为醇或醚,而羧酸被还原为醇或醛。
  • PROTEIN CROSS-LINKING INHIBITOR
    申请人:Mikoshiba Katsuhiko
    公开号:US20110212919A1
    公开(公告)日:2011-09-01
    The present invention provides a protein cross-linking inhibitor containing a compound represented by any of the following formulas ( 1 )-( 13 ), or a pharmaceutically acceptable salt thereof: R 3 —[—X—B(ZR 1 )—Y—B(ZR 2 )—W—] n —R 4 ,  (1) R 3 —[—X—B(ZR 1 )—Y—] n —R 4 ,  (2) R 3 —[—B(ZR 1 )—Y—B(ZR 2 )—W—] n —R 4 ,  (3) R 3 —[—X—B(ZR 1 )—] n —R 4 ,  (4) R 3 —[—B(ZR 2 )—W—] n —R 4 ,  (5) R 3 —X—B(ZR 1 )-T[B(ZR 2 )—W—R 4 ] 2 ,  (6) R 3 —B(OH) 2 ,  (7) R 3 —B(ZR 1 )—X—B(ZR 2 )—R 4 ,  (8) R 3 —B(R 1 )—O—B(R 2 )—R 4 ,  (9) R 3 —[—X—B(ZR 1 )—Y—B(ZR 2 )—] n —R 4 ,  (10) R 3 —[—X—B(ZR 1 )—Y—B(ZR 2 )—W-Q-] n —R 4 ,  (11) R 3 —[—P—X—B(ZR 1 )—Y—B(ZR 2 )—W—] n —R 4 ,  (12) [R 3 —X—B(ZR 1 )—Y] 2 B(ZR 2 ),  (13) wherein each symbol is as defined in the DESCRIPTION.
    当前发明提供了一种含有由以下任一公式(1)-(13)表示的化合物的蛋白交联抑制剂,或其药用可接受的盐:R3—[—X—B(ZR1)—Y—B(ZR2)—W—]n—R4,  (1)R3—[—X—B(ZR1)—Y—]n—R4,  (2)R3—[—B(ZR1)—Y—B(ZR2)—W—]n—R4,  (3)R3—[—X—B(ZR1)—]n—R4,  (4)R3—[—B(ZR2)—W—]n—R4,  (5)R3—X—B(ZR1)-T[B(ZR2)—W—R4]2,  (6)R3—B(OH)2,  (7)R3—B(ZR1)—X—B(ZR2)—R4,  (8)R3—B(R1)—O—B(R2)—R4,  (9)R3—[—X—B(ZR1)—Y—B(ZR2)—]n—R4,  (10)R3—[—X—B(ZR1)—Y—B(ZR2)—W-Q-]n—R4,  (11)R3—[—P—X—B(ZR1)—Y—B(ZR2)—W—]n—R4,  (12)[R3—X—B(ZR1)—Y]2B(ZR2),  (13)其中每个符号如说明书中所定义。
  • PYRAZOLONAPHTHYRIDINONE DERIVATIVES AS METAP2 INHIBITORS (METHIONINE AMINOPEPTIDASE TYPE-2)
    申请人:SANOFI
    公开号:US20160060265A1
    公开(公告)日:2016-03-03
    The invention related to pyrazolonaphthyridinone derivatives of formula (I) to their preparation and to their therapeutic use as selective inhibitors of type 2 methionine aminopeptidase (hMETAP2).
    该发明涉及公式(I)的吡唑萘啉酮衍生物,以及它们的制备和治疗用途,作为选择性抑制剂2型甲硫氨酰肽酶(hMETAP2)。
  • Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents
    申请人:MITSUI TOATSU CHEMICALS, Inc.
    公开号:EP0268878A2
    公开(公告)日:1988-06-01
    Disclosed herein are salicylic acid copolymers having a weight average molecular weight of 500 10,000 and obtained (a) by condensing salicylic acid (i) with a benzyl alcohol (ii) and/or benzyl ether (iii) or a benzyl halide (iv) in the presence of an acid catalyst or (b) by reacting a co-condensation resin of (i) and (ii) and/or (iii) with (iv) or (c) by reacting a co-condensation resin of (i) and (ii) and/or (iii) or (iv) with a styrene derivative in the presence of an acid catalyst; multivalent metal salts of the salicylic acid copolymers; color-developing agents comprising the multivalent metal salts; and color-developing sheets suited for pressure-sensitive copying paper and comprising the color-developing agents. Their production processes are also disclosed.
    本文公开了水杨酸共聚物,其重量平均分子量为 500 10、000 的水杨酸共聚物;(a)在酸催化剂存在下,将水杨酸(i)与苄醇(ii)和/或苄醚(iii)或苄基卤化物(iv)缩合而得,或(b)将(i)和(ii)和/或(iii)的共缩合树脂与(iv)反应而得,或(c)在酸催化剂存在下,将(i)和(ii)和/或(iii)或(iv)的共缩合树脂与苯乙烯衍生物反应而得;水杨酸共聚物的多价金属盐;由多价金属盐组成的显色剂;以及由显色剂组成的适用于压敏复印纸的显色薄片。此外,还公开了它们的生产工艺。
  • Aralkylphenolic resin molding material
    申请人:MITSUI TOATSU CHEMICALS, Inc.
    公开号:EP0284385A2
    公开(公告)日:1988-09-28
    An aralkylphenolic resin molding material comprises an aralkylphenolic resin prepared by reacting a compound represented by the general formula (I) with a phenolic compound, mountain leather and optionally glass fiber being incorporated in the resin as inorganic filler materials. The aralkylphenolic resin molding material contains no asbestos but has equal or better characteristics as compared with molding materials containing asbestos. In particular the present aralkylphenolic resin has excellent heat resistance, mechanical characteristics and electrical characteristics.
    一种芳基酚醛树脂成型材料包括一种芳基酚醛树脂,由通式 (I) 所代表的化合物与酚类化合物反应制备而成。 山皮和玻璃纤维作为无机填充材料加入树脂中。 这种芳基酚醛树脂模塑材料不含石棉,但与含石棉的模塑材料相比,具有相同或更好的特性。尤其是本产品的芳基酚醛树脂具有极佳的耐热性、机械特性和电气特性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐